International phase I study protocol to develop a patient-reported outcome measure for adolescents and adults receiving gender-affirming treatments (the GENDER-Q)
Anne F. Klassen(McMaster University), Andrea L. Pusic(Memorial Sloan Kettering Cancer Center), Thomas Satterwhite(Align Technology (United States)), Kinusan Savard(Fleming College), Giancarlo McEvenue, Danny A. Young‐Afat(Amsterdam University Medical Centers), Margriet G. Mullender(Amsterdam Neuroscience), John L. Semple(University of Toronto), Manraj Kaur(Brigham and Women's Hospital), Natasha Johnson(McMaster University), Will Rowe(McMaster University), Jens Ahm Sørensen(University of Southern Denmark), Müjde Özer(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tim C. van de Grift(Amsterdam Neuroscience), Shane D. Morrison(University of Washington Medical Center), Lotte Poulsen(Odense University Hospital), Maeghan van der Meij-Ross(Amsterdam UMC Location Vrije Universiteit Amsterdam), Baudewijntje P.C. Kreukels(Amsterdam University Medical Centers)
Cited by 130
Related Papers
Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling
|New England Journal of Medicine|2003|697
The quality of life in acne: a comparison with general medical conditions using generic questionnaires
|British Journal of Dermatology|1999|521
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer
|European Journal of Cancer|2015|386
Sentinel Node Biopsy in Head and Neck Squamous Cell Cancer: 5-Year Follow-Up of a European Multicenter Trial
|Annals of Surgical Oncology|2010|259
In Vivo Visualization of Amyloid Deposits in the Heart with <sup>11</sup>C-PIB and PET
|Journal of Nuclear Medicine|2012|258